We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AKM LINEZOLID, PHARMACOR LINEZOLID (Pharmacor Pty Ltd)
Product name
AKM LINEZOLID, PHARMACOR LINEZOLID
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
96 working days (255)
Active ingredients
Linezolid
Registration type
New generic medicine
Indication
AKM LINEZOLID, PHARMACOR LINEZOLID (tablets) is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.